Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shum, Kenny ^a,e   Alperin, Peter ^a,e   Shalnova, Svetlana ^b   Boytsov, Sergey ^b   Kontsevaya, Anna ^b   Vigdorchik, Alexey ^c   Guetz, Adam ^a,e   Eriksson, Jennifer ^a   Hughes, David ^d  

^a Archimedes ^*  (Sweden)

^b NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

^c Novartis Pharma LLC   (Russian Federation)

^d NOVARTIS PHARMA AG   (Switzerland)

^e EVIDERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST CONTROL; DISEASE MODEL; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH PROGRAM; HEART INFARCTION; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SMOKING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; ADULT; ADVERSE OUTCOME; DISEASE SIMULATION; ECONOMIC ASPECT; FEMALE; HEART DEATH; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RISK REDUCTION; SENSITIVITY ANALYSIS; UNITED STATES; CARDIOVASCULAR DISEASES; COST BENEFIT ANALYSIS; ECONOMICS; MEDICATION COMPLIANCE; PATHOPHYSIOLOGY; STATISTICAL MODEL; THEORETICAL MODEL;

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; MODELS, ECONOMIC; MODELS, THEORETICAL; RISK FACTORS; RUSSIA;

EID: 84929051794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103280/     Document Type: Article

References (63)

1. Russian Federal Service of State Statistics (2011) [Healthcare in Russia]. Available: http://www.gks.ru/bgd/regl/b11-34/isswww.exe/stg/d01/01-86. htm.Accessed June 19, 2014.
2. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, et al. (2012) European cardiovascular disease statistics 2012. European Heart Network, Brussels, European Socity of Cardiology, Sophia Antipolis. Available: http://www.escardio.org/about/Documents/EU-cardiovascular-disease-statistics- 2012.pdf. Accessed June 19, 2014.
3. Marquez PV (2005) Dying too young: addressing premature mortality and ill health due to non-communicable diseases and injuries in the Russian Federation. World Bank. Available: http://siteresources.worldbank.org/INTECA/Resources/ Dying-too-Young-Summary-UPDATED-Oct-19.pdf. Accessed June 19, 2014.
4. Eberstadt N, Shah A (2009) Russia's demographic disaster. American Enterprises Institute for Public Policy Research. Available: http://www.aei.org/files/2009/05/19/RO%20Special%20Edition%20Eberstadt-g.pdf. Accessed June 19, 2014.
5. Shalnova SA, Deev AD (2011) Russian mortality trends in the early XXI century: official statistics data. Cardiovasc Ther Prev 10: 5-10.
6. Kontsevaya A, Kalinina A, Oganov R (2013) Econcomic burden of cardiovascular diseases in the Russian Federation. Value Health Reg Issues 2: 199-204.
7. Oganov RG, Timofeeva TN, Koltunov IE, Konstantinov VV, Balanova YA, et al. (2011) Arterial hypertension epidemiology in Russia: the results of 2003-2010 federal monitoring. Cardiovasc Ther Prev 10: 9-13.
8. The Health and Social Care Information Centre (2012) Health survey for England 2011: health, social care and lifestyles. Summary of key findings. Available: http://www.hscic.gov.uk/catalogue/PUB09300/HSE2011-Sumbklet.pdf. Accessed June 19, 2014.
9. Yoon SS, Burt V, Louis T, Carroll MD (2012) Hypertension among adults in the United States, 2009-2010. NCHS data brief No. 107. National Center for Health Statistics. Available: http://www.cdc.gov/nchs/data/databriefs/db107.pdf. Accessed June 19, 2014.
10. Godet-Mardirossian H, Girerd X, Vernay M, Chamontin B, Castetbon K, et al. (2012) Patterns of hypertension management in France (ENNS 2006-2007). Eur J Prev Cardiol 19: 213-220.
11. Wilkins K, Campbell NR, Joffres MR, McAlister FA, Nichol M, et al. (2010) Blood pressure in Canadian adults. Health Rep 21: 37-46.
12. Belousov Y, Leonova MV, Steinberg LL, Galitsky A, Belousov DY (2009) Monitoring of the medical-social aspects of the efficiency of the treatment of patients with arteiral hypertension in Russia (according to the results of the PIFAGOR III pharmacoepidemiologic study). Problems of Standardization in Healthcare No. 7-8.
13. Tolpygina SN, Polyanskaya TN, Martsevich SY (2013) Treatment of patients with chronic ischemic heart disease in real clinical practice according to the data from PROGNOZ IBS register (part 1). Rational Pharmacother Card 9: 138-142.
14. Marcevich SY, Ginzburg ML, Kutishenko NP, et al (2012) The LIS study (Lyubertsy study of mortality in patients with acute myocardial infarction). Evaluation of the pharmacotherapy. Part 1. Treatment of patients before myocardial infarction and its influence on hospital mortality rate. Rational Pharmacother Card 8: 681-684.
15. Mozheyko M, Eregin S, Vigdorchik A, Hughes D (2012) A cross-sectional survey of hypertension diagnosis and treatment practices among physicians in Yaroslavl Region, Russia. Adv Ther 29: 1016-1025.
16. Kobalova ZD, Starostina EG, Kotovskaia IV, Villeval'de SV, Baranova EI, et al. (2008) [Antihypertensive treatment compliance and obstacles to its improvement. Results of Russian program ARGUS-2]. Ter Arkh 80: 76-82.
17. Roberts B, Stickley A, Balabanova D, McKee M (2012) Irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health 66: 482-488.
18. Greenberg HM, Galyavich AS, Ziganshina LE, Tinchurina MR, Chamidullin AG, et al. (2005) Identification and management of patients with hypertension in the polyclinic system of the Russian Federation. Am J Hypertens 18: 943-948. (Pubitemid 41040265)
19. Kobalava ZD, Kotovskaia IV, Starostina EG, Villeval'de SV, Luk'ianova EA, et al. (2007) [Problems of a physician-patient interaction and control of arterial hypertension in Russia. Main results of scientific-practical program ARGUS-2]. Kardiologiia 47: 38-47.
20. Kobalava ZD, Kotovskaya YV, Villevalde SV, Moiseev VS, Russian ARGUS-2 study (2009) Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study. Curr Med Res Opin 25: 2229-2237.
21. US Department of Health and Human Services Services (2004) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No 04-5230.
22. Schlesinger L, Eddy DM (2002) Archimedes: a new model for simulating health care systems the mathematical formulation. J Biomed Inform 35: 37-50.
23. Schuetz CA, Alperin P, Guda S, van Herick A, Cariou B, et al. (2013) A standardized vascular disease health check in Europe: a cost-effectiveness analysis. PLoS One 8: 1-11.
24. Eddy D, Cohen M, Shum K, Dziuba J (2013) Validation methodology and results. ARCHeS Simulator 2.5. Archimedes. Available: http://archimedesmodel. com/sites/default/files/Archimedes-Validation-ARCHeS-Simulator-2.5.pdf. Accessed June 19, 2014.
25. World Health Organization (2012) World Health Statistics 2012. Available: http://apps.who.int/iris/bitstream/10665/44844/1/9789241564441-eng.pdf. Accessed June 19, 2014.
26. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: e6-245.
27. Posnenkova OM, Kiselev AR, Gridnev VI, Shvartz VA, Dovgalevsky PY, et al. (2011) Pharmacotherapy quality in patients with arterial hypertension observed in primary care practice. Hypertension register data. Rational Pharmacother Cardiol 7: 725-732.
28. World Health Organization (2009) Global Adult Tobacco Survey (GATS). Russian Federation 2009 Country Report. Available: http://www.who.int/tobacco/ surveillance/en-tfi-gats-russian-countryreport.pdf. Accessed June 19, 2014.
29. Russian Federation Statistical Service (2010) The Demographic Yearbook of Russia. 2010: Statistical Handbook. Moscow. Available: http://www.gks.ru/doc- 2010/demo.pdf. Accessed June 19, 2014.
30. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al. (2014) 2014 Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 311: 507-520.
31. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J 34: 2159-2219.
32. Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD (2009) Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial. Hypertension 54: 32-39.
33. Oparil S, Melino M, Lee J, Fernandez V, Heyrman R (2010) Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther 32: 1252-1269.
34. Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338: b1665.
35. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, et al. (2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 92: 152-160. (Pubitemid 36835963)
36. Dudl RJ, Wang MC, Wong M, Bellows J (2009) Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications. Am J Manag Care 15: e88-e94.
37. Huxley RR, Perkovic V (2014) The modifiable burden of worldwide mortality from cardiovascular disease. Lancet Diabetes Endocrinol May 16 Epub ahead of print.
38. Mozheyko M, Eregin S, Vigdorchik A, Tobe S, Campbell N, et al. (2013) Changes in hypertension treatment in the Yaroslavl region of Russia: improvements observed between 2 cross-sectional surveys. J Clin Hypertens (Greenwich) 15: 918-924.
39. Chazova IE, Ratova LG, Boytsov SA, et al, for the Experts Committe of the Russian Medical Society of Hypertension and Russian Scientific Society of Cardiology (2010) Diagnostics and treatment of arterial hypertension. Russian Guidelines (4th Review): Systemic Hypertension 3: 5-26.
40. Guallar E, Banegas JR, Blasco-Colmenares E, et al. (2011) Excess risk attributable to traditional cardiovascular risk factors in clinical practice setting across Europe - The EURIKA Study. BMC Public Health 11: 704.
41. Pension Fund of the Russian Federation. Pension system principles. Available at: http://www.pfrf.ru/ot-en/system/. Accessed June 19, 2014.
42. International Monetary Fund (2011) World economic outlook database. Available: http://www.imf.org/external/pubs/ft/weo/2011/02/weodata/index.aspx. Accessed June 19, 2014.
43. World Health Organization (2013) Universal Health Coverage 2013. Available: http://www.who.int/universal-health-coverage/en/. Accessed June 19, 2014.
44. World Health Organization (2008) World health report-primary health care: now more than ever. Available: http://www.who.int/whr/2008/08-contents-en.pdf. Accessed June 19, 2014.
45. Wong MC, Wang HH, Wong SY, Wei X, Yang N, et al. (2012) Performance comparison among the major healthcare financing systems in six cities of the Pearl River Delta region, mainland China. PLoS One 7: e46309.
46. Cené CW, Roter D, Carson KA, Miller ER, III, Cooper LA (2009) The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med 24: 1057-1064.
47. Oganov RG, Shalnova SA, Maslennikova GY, Deev AD (2001) The role of health lifestyle strategies for public health protection. Ross Med Vesti 3: 34-37.
48. Petrukhin IS, Lunina EY (2011) Cardiovascular disease risk factors and mortality in Russia. Public Health Rev 33: 436-449.
49. Zaridze D, Lewington S, Boroda A, Scelo G, Karpov R, et al. (2014) Alcohol and mortality in Russia: prospective observational study of 151 000 adults. Lancet 383(9927): 1465-1473 Epub 2014 Jan 31.
50. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH (2007) Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 120: 713-719. (Pubitemid 47176510)
51. Taylor AA, Shoheiber O (2003) Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 9: 324-332.
52. Chazova IE, Dongre N, Vigdorchik AV (2011) Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension. Adv Ther 28: 134-149.
53. Karpov Y, Dongre N, Vigdorchik A, Sastravaha K (2012) Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension. Adv Ther 29: 134-147.
54. Kontsevaya A, Kalinina A, Deev D (2010) Cost-effectiveness of the 5-year cardiovascular program in Russian population. J Hypertens 28: e239. Oral session 6C.
55. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, et al. (2007) Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 370: 2054-2062. (Pubitemid 50007974)
56. Tu JV, Nardi L, Fang J, Liu J, Khalid L, et al. (2009) National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 180: E118-125.
57. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, et al. (2011) Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 183: 1007-1013.
58. Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA, et al. (2006) The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 47: 22-28. (Pubitemid 43177810)
59. Jaffe MG, Lee GA, Young JD, Sidney S, Go AS (2013) Improved blood pressure control associated with a large-scale hypertension program. JAMA 310: 699-705.
60. Cifková R, Skodová Z, Lánská V, Adámková V, Novozámská E, et al. (2004) Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 18: 571-579. (Pubitemid 39173535)
61. Cífková R, Škodová Z, Bruthans J, Adámková V, Jozífová M, et al. (2010) Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 211: 676-681.
62. Davidkovová H, Kysely J, Kriz B, Vojtisek P, Bobák M (2013) Trends in cardiovascular mortality and hospitalisations, and potential contribution of inhospital case-fatality rates to changes in national mortality in the Czech Republic 1994-2009. Heart 99: 409-416.
63. Leon DA, Saburova L, Tomkins S, Andreev E, Kiryanov N, et al. (2007) Hazardous alcohol drinking and premature mortality in Russia: a population based case-control study. Lancet 369: 2001-2009. (Pubitemid 46899180)